gilead sciences news - Search News

Gilead Sciences stock nears its all-time high

MarketWatch · 2h

Gilead Sciences Inc. stock underperforms Thursday when compared to competitors

The stock's fall snapped a five-day winning streak.

bovnews · 4h

Gilead Sciences, Inc. (GILD) Stock Price Reaches $84.74: What Factors Are Influencing This Level?

On Wednesday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $84.74 which represents a slight increase of $0.80 or 0.95% from the prior close of $83.94. The stock opened at $83.

Zacks.com on MSN · 14d

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It

Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

MarketWatch · 14d

Gilead Sciences Inc. stock rises Thursday, still underperforms market

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy. Back To Top

invezz on MSN · 14d

Gilead Sciences stock nears its all-time high: buy or sell?

Gilead Sciences (GILD) stock price has staged a strong comeback this year, helped by strong earnings and a recent $40 million settlement with American authorities. It has risen for two consecutive weeks,

HIV, Gilead and Hetero Drugs

BioSpace · 7h

Gilead Partners With Generics Developers to Provide HIV Drug to Low-Income Countries

Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for treating human immunodeficiency virus in heavily pre-treated adults with multidrug-resistant infections.

Reuters on MSN · 22h

Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries

Gilead Sciences said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell cheaper copycat versions of its HIV prevention medicine in 120 low and lower-middle income countries.

STAT · 1d

Gilead strikes voluntary licensing deals in poor countries for its pricey HIV drug

Gilead will license the HIV drug lenacapavir, a twice-yearly injectable, to six generic makers for 120 countries.

Gilead to donate remdesivir for emergency use against Marburg disease in Rwanda

Gilead Sciences said on Thursday it would donate about 5,000 vials of its antiviral drug remdesivir to the Rwanda Medical ...

22hon MSN

Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries

The drugmaker Gilead Sciences on Wednesday announced a plan to allow six generic pharmaceutical companies in Asia and North ...

Daily9h

Gilead Sciences inks pacts with Dr Reddy's Labs, Emcure, Hetero and 3 others for HIV drug Lenacapavir

Gilead Sciences, Inc. has announced that it has signed non-exclusive, royalty-free voluntary licensing agreements with six ...

Gilead Partners 6 Pharma Cos. To Provide Generic Lenacapavir In High-incidence Countries

(RTTNews) - Gilead Sciences, Inc. (GILD) Wednesday said it has signed royalty-free licensing agreements with six pharmaceutical manufacturers to manufacture and supply generic versions of the ...

17h

Ferozsons Partners With Gilead Sciences to Produce HIV Medicine in Pakistan

Ferozsons Laboratories Limited (PSX: FEROZ) has entered into a non-exclusive voluntary license agreement with Gilead Sciences ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Related topics